ORTHO
BULLETS
Free CME
Join now
Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 210102

Outcome Measure Tools Minimal Clinically Important Difference (MCID) The difference in outcome measures that will have clinical relevance QID: 210102 (OBQ17.15)
In scope icon L 2 A
QID 210102 (Type "210102" in App Search)
A pharmaceutical company is marketing a new intra-articular injectable therapy that they claim is superior to intra-articular steroid injection for the treatment of knee osteoarthritis. Patients undergoing this new therapy report a larger improvement in their Knee injury and Osteoarthritis Outcome Score (KOOS) when compared to patients undergoing intra-articular steroid injections. This difference is reported with a p-value of 0.04. Which of the following is true when considering whether or not to use this new therapy on your patients?
Type in at least one full word to see suggestions list
Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options